Stephen C. Glover

Stephen C. Glover appears in our data through filings on Oncolytics Biotech Inc. shares, published by SEDI. We count 2 filings, every one of them for a trade on 1 June 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 4 June 2026: an option exercise of €63k, in Oncolytics Biotech Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.